- Companies
- Oxylabs
Oxylabs Revenue, Valuation, Funding & Investors
Oxylabs is valued at $3.6B as of July 2026, a 10.3x multiple on its last reported $350M revenue.
Last Oxylabs valuation
$3.6B
Series A · Jul 2026
Last Oxylabs funding round
$130M
Series A · Jul 2026
Oxylabs revenue
$350M
Series A · Jul 2026
Key investors in Oxylabs
Warburg Pincus
About Oxylabs
Oxylabs is a Vilnius-based provider of proxy networks and web scraping infrastructure. Established in 2015, the company supplies residential, datacenter, and mobile proxies to enterprises for data collection, market research, and ad verification. Its ethical proxy pools exceed millions of IPs worldwide, supporting compliance-focused operations in e-commerce and competitive intelligence sectors.
Founded
2015
HQ
Website
Status
Privately held
Customer focus
B2B
Revenue model
Usage-based, Subscription
Revenue
$350M (Jul 2026)
Valuation
$3.6B (Jul 2026)
Oxylabs Valuation
Oxylabs is currently valued at $3.6B, based on its Series A in July 2026.
The $130M round was led by Warburg Pincus.
Oxylabs valuation by funding round
| Date | Stage | Valuation | Revenue Multiple |
|---|---|---|---|
| Jul 2026 | Series A | $3.6B | 10.3x |
Oxylabs Revenue
Oxylabs' latest recorded revenue is $350M, as of its Series A in July 2026. At a $3.6B valuation, that implies a 10.3x revenue multiple.
Oxylabs revenue by funding round
| Date | Revenue * | Valuation | Revenue Multiple | Stage |
|---|---|---|---|---|
| Jul 2026 | $350M | $3.6B | 10.3x | Series A |
* Revenue (or ARR) figures are the values recorded alongside each funding round. Typically run-rate revenue at the time of the deal, or a reported LTM (last 12 months) revenue.
Oxylabs Funding History
Oxylabs has raised a total of $130M across 1 funding round.
Oxylabs funding rounds
| Date | Stage | Investors | Raised | Valuation | Deal Summary |
|---|---|---|---|---|---|
| Jul 2026 | Series A | Warburg Pincus (lead) | $130M | $3.6B | Oxylabs, a Vilnius-based data infrastructure platform, secured a $130 million growth-stage investment from Warburg Pincus through its Warburg Pincus Capital Solutions Founders Fund, valuing the company at approximately $3.6 billion post-money. This marks Oxylabs' first external financing since its founding in 2015 after a decade of bootstrapped growth, officially cementing its status as a Lithuanian unicorn and the first proxy industry company with a publicly confirmed unicorn valuation. The capital will be deployed to expand Oxylabs' global proxy network, accelerate development of next-generation web-scraping tools for AI model training and agentic applications, bolster its technology stack, and pursue strategic acquisitions to support real-time internet data needs for AI advancements. Oxylabs operates as a leading provider of enterprise-grade web data extraction infrastructure and services, positioning itself around scale and reliability in web data acquisition for AI and agentic applications. The transaction was advised by Goldman Sachs Bank Europe SE as sole placement agent, Deloitte Lithuania as financial and tax advisor, with legal counsel from Tegos, Norton Rose Fulbright US, and Norton Rose Fulbright Netherlands. Warburg Pincus' Capital Solutions Founders Fund, which closed in September 2024 with over $4 billion in commitments, focuses on growth capital, acquisitions, shareholder liquidity, and strategic purposes. |
Who has invested in Oxylabs?
1 investor has backed Oxylabs across its funding rounds, including Warburg Pincus.
Lead investors include Warburg Pincus.
Oxylabs Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
This data is available for Pro users. Sign up to see all 1 Oxylabs investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAcquisitions by Oxylabs
Oxylabs has acquired 2 companies to date.
Last acquisition by Oxylabs was on June 19th 2025. Oxylabs acquired ScrapingBee for undisclosed valuation.
Latest Acquisitions by Oxylabs
| Description | ScrapingBee is a Belgium-based web scraping API that renders JavaScript-heavy pages using headless Chrome browsers. It proxies requests through residential IPs and handles CAPTCHAs for e-commerce price monitoring and lead generation. | Webshare Software is a provider of residential proxy servers for data aggregation and web scraping. Offering over 30 million IPs across 190 countries, the service supports enterprise applications with unlimited bandwidth plans starting at affordable rates. Headquartered in Romania, Webshare delivers 99.99% uptime, rotating proxies, and API access for SEO monitoring, market research, and ad verification tasks. |
| HQ Country | ||
| HQ City | Paris | San Francisco, CA |
| Deal Date | 19 Jun 2025 | 20 Sep 2022 |
| Valuation | undisclosed | $50M |
| EV/Revenue | ||
| EV/EBITDA | ||
This data is available for Pro users. Sign up to see all Oxylabs acquisitions and their M&A valuation multiples. Start Free Trial | ||
Oxylabs Competitors
Oxylabs competitors include listed companies like Dameng Database and Teradata, and private ones like Origin Quantum, Dataiku, Celestia and Cribl.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Private | - | - | $3.5B | - | ||
| Private | $150M | - | $3.7B | 24.7x | ||
| Private | - | - | $3.5B | - | ||
| Private | $100M | - | $3.5B | 35.0x | ||
| Publicly listed | $195M | $84M | $3.4B | 12.5x | ||
| Publicly listed | $1.7B | $285M | $2.7B | 1.5x |
Oxylabs Public Comps
Oxylabs is still privately-owned, but its public comps include Dameng Database, Xunce Technology, Teradata, Business-intelligence, Transwarp, TRS Information Technology, CommVault Systems, e-Hualu, BTQ Technologies and Zhongfu Information.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $195M | $84M | 15.3x | 12.5x | 35.5x | 27.6x | |||
| $192M | ($15M) | 21.3x | 13.4x | (264.0x) | 415.8x | |||
| $1.7B | $285M | 1.4x | 1.5x | 8.4x | 5.3x | |||
| $389M | $54M | 6.6x | 5.9x | 47.7x | - | |||
| $67M | ($31M) | 27.5x | 28.0x | (59.8x) | - | |||
| $76M | ($20M) | 19.3x | 19.7x | (73.5x) | 478.8x | |||
| $1.2B | $84M | 5.2x | 5.0x | 72.9x | 23.2x | |||
| $69M | ($310M) | 24.1x | - | (5.4x) | - | |||
This data is available for Pro users. Sign up to see all Oxylabs competitors and their valuation data. Start Free Trial | ||||||||
Common questions about Oxylabs
| When was Oxylabs founded? | Oxylabs was founded in 2015. |
| Where is Oxylabs headquartered? | Oxylabs is headquartered in Vilnius, Lithuania. |
| Is Oxylabs publicly listed? | No, Oxylabs is a private, VC-backed company. |
| What is Oxylabs' valuation? | Oxylabs was last valued at $3.6B in its Series A in July 2026. |
| How much funding has Oxylabs raised? | Oxylabs has raised $130M across 1 funding round. |
| What was Oxylabs' last funding round? | Oxylabs' last funding round was a $130M Series A in July 2026, led by Warburg Pincus. |
| Who are Oxylabs' investors? | Oxylabs' investors include Warburg Pincus. |
| What is Oxylabs' revenue? | Oxylabs' latest recorded revenue is $350M (July 2026). |
| What is Oxylabs' revenue multiple? | Oxylabs' latest valuation implies a 10.3x revenue multiple ($3.6B valuation on $350M of revenue). |
| Which companies are comparable to Oxylabs? | Companies comparable to Oxylabs include Origin Quantum, Dataiku, Celestia, Cribl, Dameng Database and Teradata. |
| How many companies has Oxylabs acquired? | Oxylabs has acquired 2 companies, including ScrapingBee and Webshare Software. |
| What was the largest acquisition by Oxylabs? | The $50M acquisition of Webshare Software in September 2022 is the largest acquisition Oxylabs has made to date. |
See companies similar to Oxylabs
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




